[Federal Register Volume 59, Number 175 (Monday, September 12, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22453]


[[Page Unknown]]

[Federal Register: September 12, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

National Heart, Lung, and Blood Institute; Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart, Lung, and Blood Special Emphasis Panel (SEP) meetings:

    Name of SEP: Clinical Units for Angiographic Trial in Women.
    Date: September 26-27, 1994.
    Time: 7:00 p.m.
    Place: Chevy Chase Holiday Inn, Chevy Chase, Maryland.
    Contact Person: David M. Monsees, Jr., Ph. D., 5333 Westbard 
Avenue, Room 550, Bethesda, Maryland 20892, (301) 594-7450.
    Purpose/Agenda: To review and evaluate contract proposal(s).
    Name of SEP: Clinical Coordinating Center for Angiographic Trial 
in Women.
    Date: September 27, 1994.
    Time: 12:00 p.m.
    Place: Chevy Chase Holiday Inn, Chevy Chase, Maryland.
    Contact Person: David M. Monsees, Jr., Ph.D., 5333 Westbard 
Avenue, Room 550, Bethesda, Maryland 20892, (301) 594-7450.
    Purpose/Agenda: To review and evaluate contract proposal(s).
    Name of SEP: Program Project Grant(s) (P01).
    Date: September 26-28, 1994.
    Time: 7:30 p.m.
    Place: Bethesda Holiday Inn, Bethesda, Maryland.
    Contact Person: Deborah P. Beebe, Ph.D., 5333 Westbard Avenue, 
Room 555, Bethesda, Maryland 20892, (301) 594-7418.
    Purpose/Agenda: To review and evaluate grant application(s).
    Name of SEP: Mode Selection Trial in Sinus Node Dysfunction 
(MOST).
    Date: October 24, 1994.
    Time: 2:00 p.m.
    Place: Hyatt Regency, Bethesda, Maryland.
    Contact Person: C. James Scheirer, Ph.D., 5333 Westbard Avenue, 
Room 557, Bethesda, Maryland 20892, (301) 594-7478.
    Purpose/Agenda: To review and evaluate grant application(s).

    These meetings will be closed in accordance with the provisions set 
forth in sec. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning Individuals associated with the applications 
and/or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 98.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: September 2, 1994.
Susan K. Feldman,
Committee Management Officer, NIH
[FR Doc. 94-22453 Filed 9-9-94; 8:45 am]
BILLING CODE 4140-01-M